Skip to main content
Journal cover image

Clinical presentation and survival outcomes of well-differentiated thyroid cancer in Filipinos.

Publication ,  Journal Article
Megwalu, UC; Ma, Y; Osazuwa-Peters, N; Orloff, LA
Published in: Cancer Med
September 2021

BACKGROUND: Filipinos have higher recurrence rates compared to other racial/ethnic groups, which might suggest a higher propensity for aggressive disease. The goal of this study was to perform a population-based analysis of disease extent at diagnosis and survival outcomes in Filipino patients with well-differentiated thyroid cancer relative to other racial/ethnic groups. METHODS: The study cohort comprised adult patients with well-differentiated thyroid cancer diagnosed between 2004 and 2015, identified in the California Cancer Registry. Rates of extrathyroidal extension, nodal metastasis, and distant metastasis were compared between Filipinos, Non-Filipino Asians, and Non-Asians using multilevel logistic regression models. Survival outcomes were compared using Cox regression models, utilizing a sequential modeling approach. RESULTS: Filipino ethnicity was associated with extrathyroidal extension (OR 1.35, 95% CI 1.11-1.63) compared with non-Asians and non-Filipino Asians. Filipino ethnicity was also associated with nodal metastasis (OR 1.32, 95% CI 1.18-1.46), and with worse OS (Hazard Ratio [HR] 1.45, 95% CI 1.20-1.75) and DSS (HR 1.51, 95% CI 1.12-2.04). After adjusting for demographic and clinical factors, Filipino ethnicity was no longer associated with OS (HR 1.03, 95% CI 0.84-1.25) or DSS (HR 0.93, 95% CI 0.68-1.28). CONCLUSION: Filipino patients with thyroid cancer are more likely to present with locoregionally advanced disease compared with non-Filipino Asians and non-Asians. Furthermore, Filipino patients have worse survival outcomes compared with non-Filipino Asians and non-Asians. However, this appears to be driven by the higher rates of locoregionally advanced disease in Filipino patients.

Duke Scholars

Published In

Cancer Med

DOI

EISSN

2045-7634

Publication Date

September 2021

Volume

10

Issue

17

Start / End Page

5964 / 5973

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Thyroid Neoplasms
  • Survival Analysis
  • Male
  • Incidence
  • Humans
  • Female
  • Cell Differentiation
  • Asian
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Megwalu, U. C., Ma, Y., Osazuwa-Peters, N., & Orloff, L. A. (2021). Clinical presentation and survival outcomes of well-differentiated thyroid cancer in Filipinos. Cancer Med, 10(17), 5964–5973. https://doi.org/10.1002/cam4.4149
Megwalu, Uchechukwu C., Yifei Ma, Nosayaba Osazuwa-Peters, and Lisa A. Orloff. “Clinical presentation and survival outcomes of well-differentiated thyroid cancer in Filipinos.Cancer Med 10, no. 17 (September 2021): 5964–73. https://doi.org/10.1002/cam4.4149.
Megwalu UC, Ma Y, Osazuwa-Peters N, Orloff LA. Clinical presentation and survival outcomes of well-differentiated thyroid cancer in Filipinos. Cancer Med. 2021 Sep;10(17):5964–73.
Megwalu, Uchechukwu C., et al. “Clinical presentation and survival outcomes of well-differentiated thyroid cancer in Filipinos.Cancer Med, vol. 10, no. 17, Sept. 2021, pp. 5964–73. Pubmed, doi:10.1002/cam4.4149.
Megwalu UC, Ma Y, Osazuwa-Peters N, Orloff LA. Clinical presentation and survival outcomes of well-differentiated thyroid cancer in Filipinos. Cancer Med. 2021 Sep;10(17):5964–5973.
Journal cover image

Published In

Cancer Med

DOI

EISSN

2045-7634

Publication Date

September 2021

Volume

10

Issue

17

Start / End Page

5964 / 5973

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Thyroid Neoplasms
  • Survival Analysis
  • Male
  • Incidence
  • Humans
  • Female
  • Cell Differentiation
  • Asian
  • 3211 Oncology and carcinogenesis